March 12-13, 2024 | Austria
In the constantly evolving field of pharmaceutical manufacturing, the imperative to embrace new technologies and innovative strategies for process control and efficiency is more pressing than ever before.
Recent advancements in aseptic processing, such as advanced isolators, robotics, and increased automation, have transformed the industry whilst simultaneously reducing the risks of contamination for sterile products. However, modern therapies - innovative, targeted treatments that result in small-batch aseptic products - require faster speeds to market and present unique sterilization and handling challenges. This dichotomy presents unique challenges for the industry to address.
Moreover, the updated Annex 1 is impacting the manufacturing of sterile products, necessitating updated requirements such as Quality Risk Management, Contamination Control Strategy, and Data Management and Compliance for Computerized Systems.
In light of these urgent needs, the 2024 ISPE Aseptic Conference will provide an ideal opportunity for participants to share progress, success stories, best practices, and lessons learned. Get ahead of the game with a focus on novel therapies, emerging technologies, and aseptic processing. We look forward to seeing you in Vienna, Austria!
March 7-8, 2024 | Singapore
A premier global platform for the International Conference on Antibiotics and Pharmacy Practice ICAPP welcomes you to its official web page. We’re very happy and proud of our pioneering and innovative renaissance, which has enabled us to introduce and research many revolutionary concepts and philosophies. To be held on 07th - 08th-Mar-2024 at Singapore
March 27, 2024 | Finland
Welcome to learn about artificial intelligence (AI) and its transformative impact on the pharmaceutical industry and healthcare at AI x PHARMA x HEALTH 2024!
April 9-11, 2024 | Germany
Welcome To The Industry’s Leading Pharma Contract Manufacturing Event.
Pharma Contract Manufacturing is the only event to focus specifically on how to improve CMO selection and partnering. We appreciate the critical role these play in delivering success for both patients and the organisation-at-large. We also appreciate that the bedrock of these relationships is collaboration from both sides, which is why we bring together leading pharmaceutical companies and CMOs to benchmark best practice in this area.
Selecting the right CMO partner is the critical decision in getting high-quality products to patients. If this relationship fails, we fail. Our companies and patients can’t afford for us to get this decision wrong. That’s why Pharma IQ is bringing together partners from across the industry to collaborate on how we make these relationships work both now and in the future. Because for the patient to succeed, we need to succeed.